Our approach combines clinical workflow understanding, software engineering and responsive support to make trial technology easier to use and govern.
Clinical research is not a single process. It is a coordinated set of activities involving participants, investigators, research sites, sponsors, CROs, data managers and operational teams. Technology is most useful when it reflects those workflows instead of forcing teams to work around the software.
eTrialTrack is built around that principle. Our portfolio connects six practical capabilities: EDC, eConsent, ePRO, RTSM/IWRS, TeleHealth and Participant Tracking.
eTrialTrack brings together business leadership, software engineering, clinical research understanding and technical support to develop and support clinical research technology.
Harendra Kumar — Founder & Director. Harendra Kumar provides business and organizational leadership for the eTrialTrack initiative, with a focus on developing practical technology solutions for clinical research workflows.
Chetna Bogra — Co-Founder & Director. Chetna Bogra contributes to the leadership and development direction of the organization, supporting the broader objective of creating practical and connected technology for clinical research operations.
The broader team is supported by contributors across software development, clinical research and workflow expertise, product development, technical implementation, customer support and quality/operational support.
Our mission is to make clinical research technology more practical, connected and understandable for the teams responsible for running clinical studies. We aim to help research teams organize important study workflows through technology that supports structured data capture, participant engagement, operational visibility and traceable processes.
Our vision is to contribute to a more connected clinical research environment where participants, investigators, sites, sponsors and research teams can work through better-coordinated digital workflows. We see clinical trial technology as an operational foundation that should help teams work with greater clarity while respecting study protocols, applicable requirements, data responsibilities and participant needs.
Clinical research technology should make complex workflows easier to manage without making the research process unnecessarily complicated. We believe effective clinical technology should connect people, data and processes while providing appropriate visibility, control and traceability.
We favor modular adoption, practical implementation, configurable workflows, connected study operations and evidence-led communication. A study should use the capabilities that fit its actual requirements rather than adopting technology simply because it is available.

Drives eTrialTrack's product vision and client partnerships — shaping every module around the real study workflows of sponsors, CROs and research sites.
LinkedIn Profile
Leads technology and compliance architecture, translating decades of EDC systems experience into an inspection-ready, audit-first clinical platform.
LinkedIn ProfileeTrialTrack was founded in April 2024 by a team with 30+ years of EDC experience — we serve the people who run studies, not just the systems around them.
eTrialTrack is built for sponsors, CROs, biotech and pharmaceutical organizations, research institutions, hospitals, investigators, research sites, and clinical operations and data management teams that need structured digital workflows.
eTrialTrack was founded in April 2024 by a team with 30+ years of EDC systems experience, 1M+ patient cases handled and 10M+ patient case records created across deployments.
The platform follows a modular adoption approach: start with one capability such as EDC and connect eConsent, ePRO, RTSM/IWRS, TeleHealth and participant tracking when the study requires a broader workflow.
eTrialTrack is headquartered at Plot No 19, Off No 102, Veer Savarkar Block, East Delhi, New Delhi — 110092, and supports teams across Mumbai, Hyderabad, Ahmedabad, Pune, Delhi and 24 countries.